Addressing Long Covid: Hearing on Improving Patient Care and Advancing Research

TLDRLong Covid, a multi-system disorder that can affect various organs, is currently disabling millions of Americans. There is no FDA-approved treatment for it, and recovery rates are rare. Long Covid can affect people of all ages and reinfection increases the risk of developing it. We need a research enterprise that matches the scale and urgency of the problem to find effective treatments.

Key insights

🔬Long Covid is a multi-system disorder that can affect various organs, including the brain, heart, kidneys, and gastrointestinal system.

💊Currently, there is no FDA-approved treatment for Long Covid.

👶👵Long Covid can affect people of all ages, from children to older adults.

🔄Reinfection increases the risk of developing Long Covid, even if a person has previously had Covid-19.

🧪Addressing Long Covid requires a multipronged approach, including understanding the biology and mechanisms of the disease, prevention strategies, and the development of effective treatments.

Q&A

What is Long Covid?

—Long Covid refers to a myriad of symptoms that continue from or develop after a Covid-19 infection. It can last for months or even years.

How many Americans are affected by Long Covid?

—At least 20 million Americans are currently dealing with Long Covid.

Is there a cure for Long Covid?

—Currently, there is no cure for Long Covid. Recovery rates are rare.

Who is at risk of developing Long Covid?

—Long Covid can affect people of all ages and demographic groups.

Does reinfection increase the risk of developing Long Covid?

—Yes, even if a person has previously had Covid-19, reinfection increases the risk of developing Long Covid.

Timestamped Summary

00:00The disease known as Long Covid was addressed on Capitol Hill, focusing on improving patient care and advancing research.

00:02Long Covid refers to a multi-system disorder that can affect various organs and can last for months or even years.

00:10Currently, there is no FDA-approved treatment for Long Covid.

00:15Reinfection increases the risk of developing Long Covid, even if a person has previously had Covid-19.

00:20At least 20 million Americans are currently dealing with Long Covid.

00:30Long Covid can affect people of all ages and demographic groups.

00:40Addressing Long Covid requires a multipronged approach, including understanding the biology and mechanisms of the disease, prevention strategies, and the development of effective treatments.

Browse more